BCPC:NSD-Balchem Corporation (USD)

COMMON STOCK | Specialty Chemicals |

Last Closing

USD 164.94

Change

-0.61 (-0.37)%

Market Cap

USD 5.28B

Volume

0.22M

Analyst Target

USD 115.33
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-13 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
LIN Linde plc Ordinary Shares

-3.75 (-0.83%)

USD 208.95B
WDFC WD-40 Company

+2.35 (+0.99%)

USD 3.04B
HWKN Hawkins Inc

+2.61 (+2.21%)

USD 2.63B
IOSP Innospec Inc

-0.25 (-0.28%)

USD 2.27B
CLMT Calumet Specialty Products Par..

+0.88 (+6.71%)

USD 1.07B
GEVO Gevo Inc

+0.05 (+4.20%)

USD 0.29B
HDSN Hudson Technologies Inc

-0.11 (-1.42%)

USD 0.24B
LWLG Lightwave Logic Inc

-0.02 (-1.89%)

USD 0.11B
FEAM 5E Advanced Materials Inc

+0.07 (+1.62%)

USD 0.08B
NTIC Northern Technologies

-0.05 (-0.68%)

USD 0.07B

ETFs Containing BCPC

KCAL 5.77 % 0.00 %

N/A

N/A
VEGB:LSE VanEck Sustainable Future.. 4.94 % 0.00 %

-2.80 (0%)

N/A
VE6I:XETRA VanEck Sustainable Future.. 4.51 % 0.00 %

+0.07 (+0%)

N/A
RIZF:F Rize Sustainable Future o.. 2.73 % 0.00 %

-0.01 (0%)

N/A
RIZF:XETRA Rize Sustainable Future o.. 0.00 % 0.00 %

-0.01 (0%)

N/A
IEAT:AU 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.19% 84% B 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.19% 84% B 64% D
Trailing 12 Months  
Capital Gain 6.23% 84% B 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.23% 84% B 62% D
Trailing 5 Years  
Capital Gain 105.40% 67% D+ 76% C+
Dividend Return 3.88% 17% F 8% B-
Total Return 109.29% 67% D+ 73% C
Average Annual (5 Year Horizon)  
Capital Gain 8.85% 58% F 64% D
Dividend Return 9.39% 58% F 63% D
Total Return 0.54% 17% F 15% F
Risk Return Profile  
Volatility (Standard Deviation) 27.75% 79% B- 63% D
Risk Adjusted Return 33.85% 68% D+ 68% D+
Market Capitalization 5.28B 94% A 89% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.